Want to join the conversation?
John DiFucci from Jefferies asks about database, the timing of general availability of R-2 and expectations of how it will be consumed by customers. $ORCL said in R-2, the company has two key features; one is in memory and the other is in multi-tenancy, both in high demand. Early adoption is expected in the cloud.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?